SLXN
Price
$2.71
Change
-$0.15 (-5.26%)
Updated
Jul 7, 04:57 PM (EDT)
Capitalization
2.99M
42 days until earnings call
Intraday BUY SELL Signals
VANI
Price
$1.35
Change
+$0.05 (+3.85%)
Updated
Jul 7, 04:59 PM (EDT)
Capitalization
112.11M
42 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SLXN vs VANI

SLXN vs VANI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
SLXN vs. VANI commentary
Jul 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLXN is a Hold and VANI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2026
Stock price -- (SLXN: $2.64 vs. VANI: $1.26)
Brand notoriety: SLXN and VANI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLXN: 3% vs. VANI: 371%
Market capitalization -- SLXN: $2.99M vs. VANI: $112.11M
SLXN [@Biotechnology] is valued at $2.99M. VANI’s [@Biotechnology] market capitalization is $112.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $134.41B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLXN’s FA Score shows that 0 FA rating(s) are green whileVANI’s FA Score has 0 green FA rating(s).

  • SLXN’s FA Score: 0 green, 5 red.
  • VANI’s FA Score: 0 green, 5 red.
According to our system of comparison, VANI is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLXN’s TA Score shows that 5 TA indicator(s) are bullish while VANI’s TA Score has 5 bullish TA indicator(s).

  • SLXN’s TA Score: 5 bullish, 3 bearish.
  • VANI’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VANI is a better buy in the short-term than SLXN.

Price Growth

SLXN (@Biotechnology) experienced а +2.92% price change this week, while VANI (@Biotechnology) price change was +4.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.78%. For the same industry, the average monthly price growth was +12.78%, and the average quarterly price growth was +1740.61%.

Reported Earning Dates

SLXN is expected to report earnings on Aug 18, 2026.

VANI is expected to report earnings on Aug 18, 2026.

Industries' Descriptions

@Biotechnology (+1.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VANI($112M) has a higher market cap than SLXN($2.99M). VANI YTD gains are higher at: 2.439 vs. SLXN (-86.224). SLXN has higher annual earnings (EBITDA): -12.91M vs. VANI (-27.36M). VANI has more cash in the bank: 19.7M vs. SLXN (2.41M). SLXN has less debt than VANI: SLXN (1.99M) vs VANI (18.3M). SLXN (0) and VANI (0) have equivalent revenues.
SLXNVANISLXN / VANI
Capitalization2.99M112M3%
EBITDA-12.91M-27.36M47%
Gain YTD-86.2242.439-3,535%
P/E Ratio0.00N/A-
Revenue00-
Total Cash2.41M19.7M12%
Total Debt1.99M18.3M11%
FUNDAMENTALS RATINGS
VANI: Fundamental Ratings
VANI
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
49

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SLXNVANI
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
49%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
35%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
42%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 6 days ago
55%
Bullish Trend 14 days ago
75%
Declines
ODDS (%)
Bearish Trend 15 days ago
89%
Bearish Trend 28 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
62%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
SLXN
Daily Signal:
Gain/Loss:
VANI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VNVCX17.04N/A
N/A
Natixis Vaughan Nelson Mid Cap C
NRGSX60.92N/A
N/A
Neuberger Genesis R6
NWGSX24.41N/A
N/A
Nationwide Renaissance Sm Cp Gr InstlSvc
GCVCX28.06N/A
N/A
Goldman Sachs Large Cp Val Insghts C
BRGKX46.69N/A
N/A
iShares Russell 1000 Large-Cap Idx K

VANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, VANI has been loosely correlated with VTVT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if VANI jumps, then VTVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VANI
1D Price
Change %
VANI100%
N/A
VTVT - VANI
60%
Loosely correlated
N/A
ADIL - VANI
37%
Loosely correlated
N/A
AXSM - VANI
36%
Loosely correlated
N/A
SCNI - VANI
34%
Loosely correlated
N/A
KYTX - VANI
28%
Poorly correlated
N/A
More